Gianaroli L, Magli M C, Ferraretti A P, Fiorentino A, Garrisi J, Munné S
Società Italiana Studi Medicina della Riproduzione, Bologna, Italy.
Fertil Steril. 1997 Dec;68(6):1128-31. doi: 10.1016/s0015-0282(97)00412-3.
To verify the percentage of chromosomally abnormal preimplantation embryos in patients with a poor prognosis and possibly to increase the chance of implantation by selecting chromosomally normal embryos.
A prospective, randomized, controlled study.
In vitro fertilization program at the Reproductive Medicine Unit of the Società Italiana Studi Medicina della Riproduzione, Bologna, Italy.
PATIENT(S): In a total of 28 stimulated cycles, the maternal age was > or = 38 years and/or the patient had > or = 3 previous IVF failures, factors that indicated a poor prognosis. After consent, 11 patients underwent preimplantation genetic diagnosis for aneuploidy, whereas 17 controls underwent assisted zona hatching.
INTERVENTION(S): Simultaneous analysis of chromosomes X, Y, 13, 18, and 21 in a blastomere biopsied from day-3 embryos. Chromosomal analysis was performed with fluorescence in situ hybridization. Assisted zona hatching was performed on day-3 embryos from the control-group patients.
MAIN OUTCOME MEASURE(S): Embryo morphology, results of fluorescence in situ hybridization, clinical pregnancies, and implantation.
RESULT(S): In the study group, a total of 61 embryos were analyzed by fluorescence in situ hybridization, and 55% were chromosomally abnormal. Embryo transfer with at least one normal embryo was performed in 10 cycles. Four clinical pregnancies resulted, with a 28.0% implantation rate. In the control group, 41 embryos were transferred in 17 cycles after the assisted zona hatching procedure, yielding four clinical pregnancies and an 11.9% implantation rate.
CONCLUSION(S): Infertile patients classified as having a poor prognosis have a high percentage of chromosomally abnormal embryos. The advantage of selecting and transferring embryos with normal fluorescence in situ hybridization results has an immediate impact on implantation.
验证预后不良患者中染色体异常的植入前胚胎的比例,并通过选择染色体正常的胚胎可能增加植入机会。
一项前瞻性、随机、对照研究。
意大利博洛尼亚意大利生殖医学学会生殖医学科的体外受精项目。
在总共28个促排卵周期中,产妇年龄≥38岁和/或患者既往有≥3次体外受精失败,这些因素表明预后不良。在获得同意后,11例患者接受了非整倍体植入前基因诊断,而17例对照患者接受了辅助透明带打孔。
对从第3天胚胎活检的一个卵裂球同时进行X、Y、13、18和21号染色体分析。采用荧光原位杂交进行染色体分析。对对照组患者的第3天胚胎进行辅助透明带打孔。
胚胎形态、荧光原位杂交结果、临床妊娠和植入情况。
在研究组中,共对61个胚胎进行了荧光原位杂交分析,其中55%染色体异常。10个周期进行了至少有一个正常胚胎的胚胎移植。获得了4例临床妊娠,植入率为28.0%。在对照组中,辅助透明带打孔术后17个周期移植了41个胚胎,获得了4例临床妊娠,植入率为11.9%。
被归类为预后不良的不孕患者染色体异常胚胎的比例很高。选择并移植荧光原位杂交结果正常的胚胎的优势对植入有直接影响。